Back
Open Access

Idarucizumab for dabigatran reversal in cardiac transplant recipients: outcomes and blood product transfusion use.

Session: Optimisation of heart transplant care and management
Topic: Heart Transplantation
Speaker: Doctor F. Sansegundo Burgueno (La Laguna, ES)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Fernando Sansegundo Burgueno

INCANIS University Hospital of the Canary Islands, La Laguna (Spain)
0 follower

5 more presentations in this session

Predictors of cardiac allograft vasculopathy and dysfunction in heart transplantation: a single-center study

Speaker: Doctor R. Carvalho (Lisbon, PT)

Access
Abstract
Like
Thumbnail

The impact of induction therapy in ECMO-HTx: early mortality and long-term outcomes

Speaker: Associate Professor J. Lee (Cheongju, KR)

Access
Abstract
Like
Thumbnail

Causes and prognostic implications of hospital admissions following successful heart transplantation

Speaker: Doctor M. Presume (Lisbon, PT) Doctor R. Carvalho (Lisbon, PT)

Access
Abstract
Like
Thumbnail

Incidence and characteristics of rejection in heart transplant recipients: analysis of a contemporary follow-up protocol based on endomyocardial biopsy.

Speaker: Doctor E. Mateu Gisbert (Las Palmas de Gran Canaria, ES)

Access
Abstract
Like
Thumbnail

Transplanting the neglected guy: hypertrophic cardiomyopathy and risk factors on the waiting list

Speaker: Doctor M. Masetti (Bologna, IT)

Access
Abstract
Like
Thumbnail

Access the full session

Optimisation of heart transplant care and management

Speakers: Doctor F. Sansegundo Burgueno, Doctor R. Carvalho, Associate Professor J. Lee, Doctor M. Presume, Doctor R. Carvalho...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources